All other malignant CNS neoplasms revealed no ANKRD55 staining besides a few ETMR samples which disclosed moderate staining in poorly differentiated areas (sensitivity—97% and specificity 95% for CNS_NBL). This evidence concerns the gene ANKRD55 and central nervous system neoplasm.